Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444236 · ClinicalTrials.gov registry record · Phase 1
Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
A Phase 1 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
NCT00444236 is a Phase 1 study that was terminated before completion, run by University of Utah. The registered enrollment target is 31 participants.
The verdict
NCT00444236, a Phase 1 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
We propose that acid reflux affects respiratory dynamics (breathing) in patients who are exercising and that athletes improve their exercise capacity with acid suppression therapy. It is our intent to determine whether treatment of GER with strong acid suppression may alleviate symptoms, improve exercise capacity, and improve quality of life.
Interventions
- DRUG Placebo
- DRUG Nexium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444236
The ClinicalTrials.gov registry entry for NCT00444236 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00444236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00444236 about?
NCT00444236 is a clinical study titled "Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression". We propose that acid reflux affects respiratory dynamics (breathing) in patients who are exercising and that athletes improve their exercise capacity with acid suppression therapy. It is our intent to determine whether treatment of GER with strong acid suppression may alleviate symptoms, improve exe...
What is the current status of trial NCT00444236?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2007-04. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00444236?
The interventions under investigation include: Placebo (DRUG), Nexium (DRUG).
Who is sponsoring clinical trial NCT00444236?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.